NBE Therapeutics
1 follower
NBE-Therapeutics is developing best-in-class cancer therapies to increase survival and improve quality of life for cancer patients worldwide. The company’s next-generation immune-stimulatory therapies are based on a proprietary, highly differentiated Antibody-Drug Conjugate (ADC) platform. This best... Read more
Org chart
Jean Engela
CEO
Jean Engela
Collapse
Flavio Solca
Chief Scientific Officer
Gerd Munzert
Chief Clinical Officer
Carl Deutsch, PhD, MBA
Chief Scientific Officer
Cornelia Baumgartner- Diolaiuti
Consulting Clinical Operations Manager
Giuliano Bellapadrona
Associate Director, Global CMC
Hüseyin Birogul
Head of Conjugation
Ina Hellmann
Program Manager Early Development
Marco Meier
Head of in vivo unit
Mariarosa Spina Horn
Human Resources Business Partner
Ulrike Fiedler
Senior Director Program Management and Pipeline Innovation
Florian Durante
Financial Controller
